Carlos Lopez Bray
Biographic Data
| ID | 7890829 |
|---|---|
| NAME | Carlos Lopez Bray |
| GIVEN NAMES | Carlos Lopez |
| FAMILY NAME | Bray |
| SIGNATURE | BRAY C L |
| AFFILIATIONS | Texas Department of State Health Services |
| ORCID | 0000-0002-6670-097X |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Perceptions of the safety, development, and approval process of severe acute respiratory syndrome coronavirus 2 (Sars-CoV-2) vaccines among individuals with Affordable Care Act health insurance in Cen…
Sendero Health Plans, an Affordable Care Act (ACA) health insurance company, conducted a cross-sectional survey in December 2020 to assess individual perceptions of the COVID-19 vaccine development and approval processes and their plan to obtain the COVID-19 vaccine in Central Texas at the time of initial availability. A logistic regression model was developed to identify factors associated with individual plans to obtain a vaccine when it became…
Sociodemographic Factors Associated with Vaccine Hesitancy in Central Texas Immediately Prior to Covid-19 Vaccine Availability
Vaccine-induced herd immunity remains the best opportunity for ending the COVID-19 pandemic. However, COVID-19 vaccine hesitancy is a real concern. In this paper, we report on vaccine hesitancy in Central Texas immediately prior to the release of the two mRNA COVID-19 vaccines in late December 2020. A total of 1648 individuals 18 years or older with health insurance living in Central Texas completed a survey on sociodemographic factors and plans …
No prominent works on this page.
Sociodemographic Factors Associated with Vaccine Hesitancy in Central Texas Immediately Prior to Covid-19 Vaccine Availability
Vaccine-induced herd immunity remains the best opportunity for ending the COVID-19 pandemic. However, COVID-19 vaccine hesitancy is a real concern. In this paper, we report on vaccine hesitancy in Central Texas immediately prior to the release of the two mRNA COVID-19 vaccines in late December 2020. A total of 1648 individuals 18 years or older with health insurance living in Central Texas completed a survey on sociodemographic factors and plans …
Perceptions of the safety, development, and approval process of severe acute respiratory syndrome coronavirus 2 (Sars-CoV-2) vaccines among individuals with Affordable Care Act health insurance in Cen…
Sendero Health Plans, an Affordable Care Act (ACA) health insurance company, conducted a cross-sectional survey in December 2020 to assess individual perceptions of the COVID-19 vaccine development and approval processes and their plan to obtain the COVID-19 vaccine in Central Texas at the time of initial availability. A logistic regression model was developed to identify factors associated with individual plans to obtain a vaccine when it became…
Immunology (2 works) · Internal Medicine (2 works) · Logistic regression (2 works) · Medicine (2 works) · SARS-CoV-2 and COVID-19 Research (2 works) · Vaccination (2 works) · Vaccine Coverage and Hesitancy (2 works) · Coronavirus disease 2019 (COVID-19 (1 work) · COVID-19 Impact on Reproduction (1 work) · Demography (1 work)